Dermal Research Market

SNAP-8

A cosmetic-facing peptide often discussed in topical anti-wrinkle and expression-line products.

CosmeticTopicalResearch Market

Also referenced as: Acetyl Octapeptide-3

Vial price compare
82 tracked offers across 82 vendors · 8 dosages
Best trust-adjusted value: Peptuvia · Strong trust · $0.37/mg
From
$0.37/mg
Tracked market history

What has the price actually done?

Daily, exact-comparability offers. Discounts use the terms known on each historical date.

-7.8% vs. Sep 6
Current low$0.37/mg
Market median$3.25/mg
Current coverage45 vendors
Observed window90 daily points
Lowest effective price Market median
Compare current offers
How this history is calculated

Effective price per mg uses an active dated override first, then the row-level historical discount, then the vendor default from the same Git revision. Aggregate chart points include exact-comparability offers only. Missing observations remain gaps; the series does not interpolate across unavailable offers or absent snapshots.

Price watch · beta

Let the market come to you.

Watch the best market price or one vendor. Get one email when SNAP-8 crosses your target, drops, or sets a new tracked low—without daily noise.

Requires a confirmed Weekly Peptide Intel address, then a separate alert confirmation. Already watching? Manage price alerts. Public prices can change; confirm the final cart total.
Public product evidence 45 certificate records for SNAP-8 products, from 26 vendors 23 reference a report on the testing laboratory's own system · 20 have a laboratory lookup that answered when last checked · 44 match a vendor product page at the same address
Status
Research Market

This name primarily lives in the research market and should not be read like an approved pharmaceutical product.

Research area
Dermal / cosmetic research

This profile is grouped by its dominant research area, not by vendor shelf placement.

Aliases
1

Acetyl Octapeptide-3

Signal depth
Low

No FDA label signal · 0 trials · 0 PubMed results

Anecdotal
Research evidence

There is essentially no indexed clinical or preclinical literature for SNAP-8. Claims rest on user reports and marketing rather than studies.

SNAP-8 has no clinical trials that name it and 0 PubMed-indexed publications and is not FDA-approved.

Human data
Lab / animal only
Trial quality
No human trials
Outcomes
No human trials
Replication
None
Literature
Established
Polymer Bulletin · 7 citations New insight into anti-wrinkle treatment: Using nanoparticles as a controlled release system to increase acetyl octapeptide-3 efficiency Journal of Analytical Science & Technology · 7 citations Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometry NASA Technical Reports Server (NASA) · 5 citations VOLTAGE DISTORTION EFFECTS OF SNAP-8 ALTERNATOR SPEED CONTROLLER AND ALTERNATOR PERFORMANCE RESULTS.
Evidence history

Re-checked nightly against the registries — tracked since 2026-07-09. No band changes yet.

Grades evidence strength, not efficacy or safety. Research-use context; not medical advice. Graded 2026-10-03 from PubMed, ClinicalTrials.gov, ISRCTN, openFDA, Health Canada, and OpenAlex — computed deterministically and refreshed nightly, with a retraction check. How we grade →

What SNAP-8 is

SNAP-8, also called acetyl octapeptide-3, is a cosmetic-oriented peptide that shows up in skin-care and anti-wrinkle product lines rather than mainstream medical peptide discussions.

Why it matters

It gives the cosmetic category more depth and helps distinguish dermal-market peptides from the metabolic and recovery compounds that dominate most peptide sites.

Regulatory context

SNAP-8 is not an FDA-approved drug. It belongs in the research and cosmetic-market category rather than any therapeutic category.

Practical reading note

Cosmetic peptides are often marketed with a softer tone than research peptides, but they still benefit from the same basic questions about evidence, formulation, and actual product category.